MOH — authorised 6 June 2014
- Marketing authorisation holder: DOW PHARM
- Status: likely_approved
MOH authorised Jublia on 6 June 2014
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 6 June 2014.
DOW PHARM holds the UAE marketing authorisation.